Stockscreener 앱 받기
1.64
0.61%
-0.01
시간 외 거래:
1.68
0.04
+2.44%
전일 마감가:
$1.65
열려 있는:
$1.65
하루 거래량:
206.06K
Relative Volume:
1.64
시가총액:
$77.02M
수익:
$84.32M
순이익/손실:
$-3.16M
주가수익비율:
-32.80
EPS:
-0.05
순현금흐름:
$-4.50M
1주 성능:
-11.59%
1개월 성능:
+12.33%
6개월 성능:
+32.26%
1년 성능:
+11.56%
1일 변동 폭
$1.63
$1.6799
1주일 범위
$1.55
$1.84
52주 변동 폭
$1.08
$2.18
Theratechnologies Inc Stock (THTX) Company Profile
THTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
THTX
Theratechnologies Inc
|
1.64 | 77.02M | 84.32M | -3.16M | -4.50M | -0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-11-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-07-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc 주식(THTX)의 최신 뉴스
Research Analysts Issue Forecasts for THTX FY2027 Earnings - Defense World
FY2025 EPS Estimates for TSE:TH Reduced by Leede Financial - MarketBeat
Theratechnologies (NASDAQ:THTX) Posts Quarterly Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Leede Financial Brokers Reduce Earnings Estimates for TSE:TH - Defense World
Theratechnologies (NASDAQ:THTX) Issues Earnings Results - MarketBeat
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Update - MarketBeat
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Up 212.7% in February - Defense World
Research Analysts Set Expectations for THTX FY2025 Earnings - Defense World
Theratechnologies’ Earnings Call: Growth Amid Challenges - TipRanks
What is Leede Financial's Estimate for THTX FY2025 Earnings? - MarketBeat
Theratechnologies Inc (THTX) Q4 2024 Earnings Call Highlights: Strong EBITDA Turnaround and ... - Yahoo Finance
Theratechnologies Reports Strong Fiscal 2024 Performance - TipRanks
Theratechnologies reports Q4 revenue $25M vs $23.45M last year - TipRanks
Theratechnologies: Fiscal Q4 Earnings Snapshot - mySA
Theratechnologies Inc reports results for the quarter ended November 30Earnings Summary - TradingView
Earnings call transcript: Theratechnologies Q4 2024 sees growth amid strategic shifts - Investing.com UK
Theratechnologies: Fiscal Q4 Earnings Snapshot -February 26, 2025 at 07:55 am EST - Marketscreener.com
Theratechnologies Achieves Record Financial Results and Secures Future Growth - TipRanks
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024 - GlobeNewswire
Theratechnologies Inc (TSX:TH) Q4 2024: Everything You Need to K - GuruFocus.com
Theratechnologies Inc (TSX:TH) Q4 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance
Theratechnologies Resumes EGRIFTA SV® Distribution Following FDA Approval - TipRanks
Theratechnologies (THTX) Stock Price, News & Analysis - MarketBeat
Theratechnologies (THTX) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Short Interest in Theratechnologies Inc. (NASDAQ:THTX) Drops By 73.4% - MarketBeat
Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025 - ADVFN
Theratechnologies (THTX) to Release Quarterly Earnings on Wednesday - MarketBeat
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update - The Manila Times
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide ... - Walla Walla Union-Bulletin
Q4 Earnings Preview: Theratechnologies CEO to Unveil Strategic Vision Alongside 2024 Financial Results - StockTitan
Theratechnologies Resumes EGRIFTA SV® Distribution Following FDA Clearance - TipRanks
Major HIV Treatment Back in Stock: FDA Greenlights EGRIFTA SV Distribution to US Pharmacies - StockTitan
Theratechnologies Resumes Distribution of EGRIFTA SV® - GlobeNewswire
Theratechnologies (TSE:TH) Trading Up 1.9%Here's Why - MarketBeat
Theratechnologies (NASDAQ:THTX) vs. Aileron Therapeutics (NASDAQ:ALRN) Head to Head Survey - Defense World
Theratechnologies Inc. (NASDAQ:THTX) Sees Large Decrease in Short Interest - MarketBeat
Theratechnologies (TSE:TH) Stock Passes Above 50-Day Moving AverageShould You Sell? - MarketBeat
Theratechnologies (NASDAQ:THTX) Shares Down 0.6%Time to Sell? - MarketBeat
Theratechnologies (NASDAQ:THTX) Trading Down 0.6% – Time to Sell? - Defense World
Theratechnologies (NASDAQ:THTX) Shares Down 0.6% – Time to Sell? - Defense World
Theratechnologies (TSE:TH) Stock Price Crosses Above 50-Day Moving AverageShould You Sell? - MarketBeat
World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering - GlobeNewswire Inc.
Impending Shortage of Theratechnologies’ EGRIFTA SV® Amid Manufacturing Shutdown - TipRanks
Theratechnologies issues update on Egrifta SV shortage (THTX:NASDAQ) - Seeking Alpha
Theratechnologies Warns of Upcoming Shortage for HIV-Induced Stomach Fat Treatment - MarketWatch
Theratechnologies Provides Update on EGRIFTA SV® Supply - GlobeNewswire
Theratechnologies Inc (THTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.45%
1.23%
자본화:
|
볼륨(24시간):